Please use this identifier to cite or link to this item: http://20.193.157.4:9595/xmlui/handle/123456789/3319
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDalawai, Vivekanand-
dc.date.accessioned2020-12-13T08:05:03Z-
dc.date.available2020-12-13T08:05:03Z-
dc.date.issued2019-
dc.identifier.urihttp://hdl.handle.net/123456789/3319-
dc.description.abstractAIMS & OBJECTIVES To evaluate the safety and efficacy of local injection of autologous skin cell suspension in donor site of split skin thickness graft with colloid dressing. MATERIALS AND METHODS- A total of 84 patients were included the study and were randomly divided into two groups ,42 patients in skin cell suspension injection into donor site group and 42 patients in colloid dressing group. Age between 18-80 years, injection of skin suspension cell into the donor site and dressing opened on 3rd day after that every 3 weeks follow up. RESULTS- in our study, we found that the mean healing time in the cases was 13 days, whereas in control group, it was found to be 17 days, P-value was very significant P value 0.001 which states that healing time was faster in cases compared to control group. CONCLUSION- In our study, there was no statistical difference in distribution of patients between the study group and control group with respect to age and sex. 4 whereas skin cell suspension injecting group showed faster healing when compared to hydrocolloid dressings with minimal complications.en_US
dc.language.isoenen_US
dc.publisherBLDE(Deemed to be University)en_US
dc.subjectEpithelizationen_US
dc.subjectSkin Cellen_US
dc.titleAutologous Skin Cell Suspension For Accelerating Re-Epithelization Of Split Thickness Donor Sitesen_US
dc.typeThesisen_US
Appears in Collections:Department of General Surgery

Files in This Item:
File Description SizeFormat 
D758 VIVEKANAND.pdf1.65 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.